197 related articles for article (PubMed ID: 37783233)
1. Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities.
Xu X; Sun B; Zhao C
Neurobiol Dis; 2023 Oct; 187():106314. PubMed ID: 37783233
[TBL] [Abstract][Full Text] [Related]
2. The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis.
Liu L; Li J; Ke Y; Zeng X; Gao J; Ba X; Wang R
Cell Mol Life Sci; 2022 Jan; 79(1):60. PubMed ID: 35000037
[TBL] [Abstract][Full Text] [Related]
3. Arsenite-induced cytotoxicity is regulated by poly-ADP ribose polymerase 1 activation and parthanatos in p53-deficient H1299 cells: The roles of autophagy and p53.
So KY; Oh SH
Biochem Biophys Res Commun; 2023 May; 656():78-85. PubMed ID: 36958258
[TBL] [Abstract][Full Text] [Related]
4. Poly (ADP-ribose) (PAR)-dependent cell death in neurodegenerative diseases.
Park H; Kam TI; Dawson TM; Dawson VL
Int Rev Cell Mol Biol; 2020; 353():1-29. PubMed ID: 32381174
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose)polymerase-1 hyperactivation in neurodegenerative diseases: The death knell tolls for neurons.
Narne P; Pandey V; Simhadri PK; Phanithi PB
Semin Cell Dev Biol; 2017 Mar; 63():154-166. PubMed ID: 27867042
[TBL] [Abstract][Full Text] [Related]
6. Parthanatos in the pathogenesis of nervous system diseases.
Wang X; Ge P
Neuroscience; 2020 Nov; 449():241-250. PubMed ID: 33039521
[TBL] [Abstract][Full Text] [Related]
7. Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.
Fatokun AA; Dawson VL; Dawson TM
Br J Pharmacol; 2014 Apr; 171(8):2000-16. PubMed ID: 24684389
[TBL] [Abstract][Full Text] [Related]
8. The dual role of poly(ADP-ribose) polymerase-1 in modulating parthanatos and autophagy under oxidative stress in rat cochlear marginal cells of the stria vascularis.
Jiang HY; Yang Y; Zhang YY; Xie Z; Zhao XY; Sun Y; Kong WJ
Redox Biol; 2018 Apr; 14():361-370. PubMed ID: 29049980
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos.
Wang Y; Dawson VL; Dawson TM
Exp Neurol; 2009 Aug; 218(2):193-202. PubMed ID: 19332058
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos).
Wang Y; Kim NS; Haince JF; Kang HC; David KK; Andrabi SA; Poirier GG; Dawson VL; Dawson TM
Sci Signal; 2011 Apr; 4(167):ra20. PubMed ID: 21467298
[TBL] [Abstract][Full Text] [Related]
11. Exploring the role of parthanatos in CNS injury: Molecular insights and therapeutic approaches.
Zhang J; Hu X; Geng Y; Xiang L; Wu Y; Li Y; Yang L; Zhou K
J Adv Res; 2024 May; ():. PubMed ID: 38704090
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
Virág L
Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
[TBL] [Abstract][Full Text] [Related]
13. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
Mashimo M; Bu X; Aoyama K; Kato J; Ishiwata-Endo H; Stevens LA; Kasamatsu A; Wolfe LA; Toro C; Adams D; Markello T; Gahl WA; Moss J
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830864
[TBL] [Abstract][Full Text] [Related]
14. Emerging role of PARP-1 and PARthanatos in ischemic stroke.
Liu S; Luo W; Wang Y
J Neurochem; 2022 Jan; 160(1):74-87. PubMed ID: 34241907
[TBL] [Abstract][Full Text] [Related]
15. Impact of Parthanatos on the Increased Risk of Onset and Mortality in Male Patients With Pulmonary Hypertension.
Lv ZC; Li F; Wang L; Zhao QH; Gang GS; Wu Y; Miao YQ; Yuan P
Am J Mens Health; 2021; 15(3):15579883211029458. PubMed ID: 34190625
[TBL] [Abstract][Full Text] [Related]
16. mTOR may interact with PARP-1 to regulate visible light-induced parthanatos in photoreceptors.
Pan YR; Song JY; Fan B; Wang Y; Che L; Zhang SM; Chang YX; He C; Li GY
Cell Commun Signal; 2020 Feb; 18(1):27. PubMed ID: 32066462
[TBL] [Abstract][Full Text] [Related]
17. Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases.
Thapa K; Khan H; Sharma U; Grewal AK; Singh TG
Life Sci; 2021 Feb; 267():118975. PubMed ID: 33387580
[TBL] [Abstract][Full Text] [Related]
18. PARP1 inhibition prevents oxidative stress in age-related hearing loss via PAR-Ca
Wan H; Chen H; Liu J; Yang B; Zhang Y; Bai Y; Chen X; Wang J; Liu T; Zhang Y; Hua Q
Free Radic Biol Med; 2024 Aug; 220():222-235. PubMed ID: 38735540
[TBL] [Abstract][Full Text] [Related]
19. Parthanatos, a messenger of death.
David KK; Andrabi SA; Dawson TM; Dawson VL
Front Biosci (Landmark Ed); 2009 Jan; 14(3):1116-28. PubMed ID: 19273119
[TBL] [Abstract][Full Text] [Related]
20. Crocetin antagonizes parthanatos in ischemic stroke via inhibiting NOX2 and preserving mitochondrial hexokinase-I.
Wu H; Li Y; Zhang Q; Wang H; Xiu W; Xu P; Deng Y; Huang W; Wang DO
Cell Death Dis; 2023 Jan; 14(1):50. PubMed ID: 36681688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
